Remove 2025 Remove Contracts Remove Intellectual Property Remove Ownership
article thumbnail

The Rise of Influencer Marketing – Contractual Considerations

IP Tech Blog

billion by 2025, at a compound annual growth rate of 32%. This blog explores some considerations surrounding influencer marketing and highlights key aspects that should be addressed in contracts to ensure a mutually beneficial and legally compliant partnership. billion in 2020 to $24.1

article thumbnail

The Rise of Influencer Marketing – Contractual Considerations

LexBlog IP

billion by 2025, at a compound annual growth rate of 32%. This blog explores some considerations surrounding influencer marketing and highlights key aspects that should be addressed in contracts to ensure a mutually beneficial and legally compliant partnership. billion in 2020 to $24.1

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What Business Owners Need to Know About the Corporate Transparency Act

LexBlog IP

CTA defines a beneficial owner as an individual who, directly or indirectly, either (1) exercises substantial control over a Reporting Company or (2) owns or controls at least 25% of the ownership interests of a Reporting Company. What is Considered an Ownership Interest? What is Substantial Control? When do I Need to Report By?

article thumbnail

Biosimilars 2020 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

In September 2020, Governor Newsom signed into law the California Affordable Drug Manufacturing Act of 2020 (SB 852), which would allow the state’s Health and Human Services Agency to contract with drug manufacturers and suppliers to produce and distribute its own label of biosimilars, biosimilar insulins, and generic drugs. Sandoz , 964 F.3d